about
What is the optimal dose for the prophylactic treatment of chronic migraine patients?Medical treatment of intracranial arterial stenosis. Are primary and secondary prevention the same thing?Asymptomatic cerebrovascular disease and systemic diagnosis in stroke, atherothrombosis as a disease of the vascular tree.Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial).Seasonal periodicity in SUNCT syndrome.Challenges of neuroprotection and neurorestoration in ischemic stroke treatment.EFNS guideline on neuroimaging in acute stroke. Report of an EFNS task force.Patients at high risk for ischemic stroke: identification and actions.Emergent cerebrovascular disease risk factor weighting: is transient ischemic attack an imminent threat?Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type.What happens to medical articles submitted in Spanish that are not accepted for publication?Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Randomized, Double-Blind, and Placebo-Controlled Trials.The neuroprotection exerted by memantine, minocycline and lithium, against neurotoxicity of CSF from patients with amyotrophic lateral sclerosis, is antagonized by riluzole.Epicardial Adipose Tissue in the General Middle-aged Population and Its Association With Metabolic Syndrome.[ASSOCIATION BETWEEN DIETARY GLYCEMIC INDEX AND GLYCEMIC LOAD AND INTIMA MEDIA THICKNESS IN A POPULATION AT HIGH CARDIOVASCULAR RISK: A SUBGROUP ANALYSIS IN THE PREDIMED TRIAL].proMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke.[Cerebral abscess treated with antibiotics and corticosteroids]Neurologic complications of intrathecal liposomal cytarabine administered prophylactically to patients with non-Hodgkin lymphoma.Leptomeningeal carcinomatosis: prognostic value of clinical, cerebrospinal fluid, and neuroimaging features.[Neuropsychiatric disorders in Parkinson's disease]Cephalalgia alopecia or nummular headache with trophic changes? A new case with prolonged follow-up.Palatal myoclonus and opioid peptides.Independent association of fibrinogen with carotid intima-media thickness in asymptomatic subjects.Prothrombin fragment 1+2 is associated with carotid intima-media thickness in subjects free of clinical cardiovascular disease.Points: Cysticercosis: a new hope.Clinical and neuroimaging characteristics of 14 patients with prionopathy: a descriptive study.Monitoring the Effect of Immunotherapy in Autoimmune Limbic Encephalitis Using 18F-FDG PET.Cerebellitis.Delirium due to brain microembolism: diagnostic value of diffusion-weighted MRI.Central sleep apnea is associated with increased risk of ischemic stroke in the elderly.Risk of ischemic stroke and lifetime estrogen exposure.Severe sleep apnea and risk of ischemic stroke in the elderly.Activation of the brainstem but not of the hypothalamus in hemicrania continua without autonomic symptoms.Birth certificate of Santiago Ramón y Cajal.Inflammation markers and prediction of post-stroke vascular disease recurrence: the MITICO study.Paroxysmal hemicrania after carotid aneurysm embolization.Upper gastrointestinal bleedingrelated to migraine: the importance of education for migraine care.Dietary fibre intake is inversely associated with carotid intima-media thickness: a cross-sectional assessment in the PREDIMED study.Neuroprotection in vascular dementia.Analysis of the vestibulo-ocular reflex time constant in patients with benign recurrent vertigo associated with head-shaking nystagmus.
P50
Q27023517-4913526A-0B26-4664-88BF-D80381C944EFQ28165839-8B154E5D-BC38-47F4-AEB1-E32460038307Q31023308-466F5FDC-9B74-4B99-9FB8-5E18588B429DQ34280852-3CF21E0E-B139-4E95-9528-45286BF3A089Q34687475-83318D82-FEF7-4C58-9A95-1C3615DE3F26Q36331046-C19B6E4E-8722-4216-998C-AE9610AB0AC5Q36658249-A07E2984-24C5-4782-B6F3-AD63F565C4C6Q36986373-3629CAC1-E912-491B-B9D1-2341CC338016Q37431259-C1B43B94-EB96-4511-8F5B-A7D60E8BC356Q37936617-83ADCB4F-2C2C-4F49-A27A-6AC56A420785Q38026313-3EE0EE0E-F4F5-4E02-B819-899C38B1AFBCQ38846550-839B4A38-47EC-4889-BFE1-C33A9E1EF2C7Q39290825-5AAFE71C-4333-4370-9E5A-8AA436F86039Q40456951-E2402DDB-38DC-4B88-AD45-24112CFBA0ECQ41142868-C7F25099-0F15-4FD5-9A8B-9A0DC3306125Q42710833-3C44657B-0413-42B3-9FC7-CE5EDB0AE9C2Q43484670-99185C0B-2045-476A-AD2B-7DC097C4F4C7Q43551846-4AA05A7E-AC4B-49CA-9E9B-37D036F96AF1Q43564547-88E51D78-3328-4EE0-B59E-3401190A6627Q43629421-3A1859EF-0CD8-4842-AD73-A1E5FB3231B1Q44231628-94BBB0C3-E7B1-4FA7-BEBA-7252BED23CDFQ44339161-4AF50E95-CFFC-4BE3-8A7F-4BE45A5AAA86Q44586637-5489175A-B112-4E31-808B-BEF31382E78EQ44797121-8708E6B0-0E3C-4194-9439-B91D45FB8AD2Q45984421-850A521A-847C-4F75-BB79-48973592BD49Q48122909-BD75618B-B0A7-451E-8F02-46FBA827D07EQ48138961-8E51F7CC-466A-4065-A7A8-C739558314F9Q48152613-800B6BC7-59A7-45D4-BB2E-3F9EDEAADED1Q48198937-39232233-4617-4326-A0D1-8473905165A6Q48270568-3CE0BC29-7129-4849-B16D-28C68310563FQ48320839-E2C519E7-9BD1-4282-A941-CC50FB134F9CQ48455002-D5CA3E34-F207-4FA0-A4DD-EEFB62AD4993Q48707569-A2BF9C47-6728-40B5-8685-91C282CAAFEBQ48718877-0EEA1092-859B-4E44-8A45-EEF30710CB16Q48720131-55ECCD57-B925-4567-AB54-3D27E34A6887Q48725235-6BBC7997-733A-4DC8-AF98-DCEFF06C3CCBQ50282299-C8C5B9C8-2384-4EB5-8F46-7E4F9FED4B45Q51422404-4F6587E1-9347-4A89-8DC1-6CEB0BA4BAFFQ51918249-1E807D6A-E0DD-4CA8-8993-72E81A6B06E9Q53799464-995E0DE5-A54B-429E-BC10-987375016D79
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Eduardo Martínez-Vila
@ast
Eduardo Martínez-Vila
@en
Eduardo Martínez-Vila
@es
Eduardo Martínez-Vila
@nl
Eduardo Martínez-Vila
@sl
type
label
Eduardo Martínez-Vila
@ast
Eduardo Martínez-Vila
@en
Eduardo Martínez-Vila
@es
Eduardo Martínez-Vila
@nl
Eduardo Martínez-Vila
@sl
prefLabel
Eduardo Martínez-Vila
@ast
Eduardo Martínez-Vila
@en
Eduardo Martínez-Vila
@es
Eduardo Martínez-Vila
@nl
Eduardo Martínez-Vila
@sl
P106
P21
P31
P496
0000-0003-3422-4726